Kepivance_(Amgen_Inc)

Category






Useful info

Kepivance_(Amgen_Inc) Brand names, Kepivance_(Amgen_Inc) Analogs

Kepivance_(Amgen_Inc) Brand Names Mixture

  • No information avaliable

    • Kepivance_(Amgen_Inc) Chemical_Formula

    C721H1142N202O204S9

    Kepivance_(Amgen_Inc) RX_link

    No information avaliable

    Kepivance_(Amgen_Inc) fda sheet

    Kepivance_(Amgen_Inc) msds (material safety sheet)

    Kepivance_(Amgen_Inc) Synthesis Reference

    No information avaliable

    Kepivance_(Amgen_Inc) Molecular Weight

    16192.7

    Kepivance_(Amgen_Inc) Melting Point

    No information avaliable

    Kepivance_(Amgen_Inc) H2O Solubility

    No information avaliable

    Kepivance_(Amgen_Inc) State

    Liquid

    Kepivance_(Amgen_Inc) LogP

    -0.650

    Kepivance_(Amgen_Inc) Dosage Forms

    Solution (IV Injection)

    Kepivance_(Amgen_Inc) Indication

    For treatment of mucositis (mouth sores)

    Kepivance_(Amgen_Inc) Pharmacology

    Used in the prevention or treatment of oral mucoscitis (mouth ulcers arising from chemotherapy), Kepivance binds to the human keratinocyte growth factor (KGF) receptor on buccal cell surfaces. Kepivance acts as both a cell growth and survival factor by stimulating epithelial cell proliferation, differentiation, and migration around the tongue and mouth. The KGF receptor is found on many tissues particularly around the tongue, esophagus, salivary gland and other gastro-intestinal tract organs.

    Kepivance_(Amgen_Inc) Absorption

    No information avaliable

    Kepivance_(Amgen_Inc) Toxicity

    No information avaliable

    Kepivance_(Amgen_Inc) Patient Information

    No information avaliable

    Kepivance_(Amgen_Inc) Organisms Affected

    Humans and other mammals